01—Abstract
Summary
Summary of the 8-K filed April 17, 2025. Cited figures are marked; the original filing is the authoritative source.
Elevance Health, Inc. (ELV) has filed a Current Report (8-K) on April 17, 2025, providing a pre-release of its first quarter 2025 financial results.
The company anticipates reporting GAAP earnings per diluted share of $9.61a, which includes approximately $2.36 per diluted share from unfavorable items. Excluding these, adjusted earnings per diluted share are expected to be $11.97. This performance reflects medical cost trends aligning with expectations, even within the Medicare Advantage segment where costs remain elevated but are consistent with the company's pricing and outlook.
Crucially for investors, Elevance Health intends to reaffirm its full-year 2025 adjusted net income guidance, projecting it to be between $34.15b and $34.85 per diluted share. The company also anticipates its Medicare Advantage membership to remain within the previously provided range of 2,200 to 2,250 thousand members for the full year. More comprehensive details regarding first quarter results and the updated full-year outlook will be disclosed during the official earnings release on April 22, 2025.
02—Key points
Key Highlights
- Elevance Health to report Q1 2025 GAAP EPS of $9.61, including $2.36 unfavorable items, with adjusted EPS of $11.97.
- Medical cost trends in Q1 2025 are in line with company expectations, including elevated but managed Medicare Advantage costs.
- Full-year 2025 Medicare Advantage membership guidance reaffirmed at 2,200-2,250 thousand members.
- Full-year 2025 adjusted net income guidance is reaffirmed at $34.15 to $34.85 per diluted share.
- The company will release detailed Q1 financial results and provide further outlook on April 22, 2025.
- The filing serves as a pre-release of financial information ahead of the official earnings announcement.
03—Questions
Frequently Asked Questions
What are Elevance Health's expected adjusted earnings per share (EPS) for the first quarter of 2025?
Elevance Health expects to report adjusted shareholders’ net income of $11.97 per diluted share for the first quarter of 2025, after excluding approximately $2.36 per diluted share of net unfavorable items.
Has Elevance Health updated its full-year 2025 guidance?
No, Elevance Health intends to reaffirm its full-year 2025 adjusted net income guidance, which remains projected to be between $34.15 and $34.85 per diluted share.
What is the company's outlook for Medicare Advantage membership in 2025?
Elevance Health continues to expect its full-year 2025 Medicare Advantage membership to be between 2,200 and 2,250 thousand members, consistent with previously issued guidance.
When will investors get more detailed information about Elevance Health's financial performance?
The company will provide additional details on its first quarter financial results and full-year outlook when it officially reports its earnings on April 22, 2025.
04—Continue